An arrayed genome-scale lentiviral-enabled short hairpin RNA screen identifies lethal and rescuer gene candidates

Assay and Drug Development Technologies

Volumn 11, Issue 3, 2013, Pages 173-190

  Bhinder, Bhavneet ^a   Antczak, Christophe ^a   Ramirez, Christina N ^a   Shum, David ^a   Liu Sullivan, Nancy ^a   Radu, Constantin ^a   Frattini, Mark G ^a   Djaballah, Hakim ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; SHORT HAIRPIN RNA;

ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENE TARGETING; GENETIC ASSOCIATION; GENOME; HOMEOSTASIS; HUMAN; HUMAN CELL; RNA INTERFERENCE;

ANIMALS; AUTOMATION; DATA INTERPRETATION, STATISTICAL; GENE LIBRARY; GENES, VIRAL; GENOME, VIRAL; HELA CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LENTIVIRUS; MICE; MICROSCOPY; MULTIGENE FAMILY; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA, VIRAL; WORKFLOW;

EID: 84875980445     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2012.475     Document Type: Article

References (62)

1. Mohr S, Bakal C, Perrimon N: Genomic screening with RNAi: results and challenges. Annu Rev Biochem 2010;79:37-64.
2. Scholl C, Fröhling S, Dunn IF, et al.: Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell 2009;137:821-834.
3. Barbie DA, Tamayo P, Boehm JS, et al.: Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009;462:108-112.
4. Colombi M, Molle KD, Benjamin D, et al.: Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addiction. Oncogene 2011;30:1551-1565.
5. Delmore JE, Issa GC, Lemieux ME, et al.: BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 2011;146:904-917.
6. Whitehurst AW, Bodemann BO, Cardenas J, et al.: Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 2007;446:815-819.
7. Cherry S: What have RNAi screens taught us about viral-host interactions? Curr Opin Microbiol 2010;12:446-452.
8. Kaelin Jr., WG: Use and abuse of RNAi to study mammalian gene function Science 2012;337:421-422.
9. Babij C, Zhang Y, Kurzeja RJ, et al.: STK33 kinase activity is nonessential in KRAS-dependent cancer cells. Cancer Res 2011;71:5818-5826.
10. Naik G: Scientists' Elusive Goal: Reproducing Study Results. The Wall Street Journal 2011; online.wsj.com.
11. Cheung HW, Cowley GS, Weir BA, et al.: Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc Natl Acad Sci USA 2011;108:12372-12377
12. Bhinder B, Djaballah H: A simple method for analyzing actives in random RNAi screens: introducing the ''H score'' for gene nomination & prioritization. Comb Chem High Throughput Screen 2012;15:686-704.
13. Antczak C, Takagi T, Ramirez CN, et al.: Live cell imaging of caspase activation for high content screening. J Biomol Screen 2009;14:956-969.
14. Sigma-Aldrich: MISSION® shRNA Library. Available online at www.sigmaaldrich com/life-science/functional-genomics-and-rnai/shrna/library-inf ormation html (last accessed on May 8, 2012)
15. Ramirez CN, Ozawa T, Takagi T, et al.: Validation of a high-content screening assay using whole-well imaging of transformed phenotypes. Assay Drug Dev Technol 2011;9:247-261
16. Antczak C, Bermingham A, Calder P, et al.: Domain-based biosensor assay to screen for EGFR modulators in live cells. Assay Drug Dev Technol 2012;10: 24-36.
17. Shum D, Bhinder B, Radu C, et al.: An image-based biosensor assay strategy to screen for modulators of the microRNA 21 biogenesis pathway. Comb Chem High Throughput Screen 2012;15:529-541
18. Karolchik D, Hinrichs AS, Furey TS, et al.: The UCSC table browser data retrieva tool. Nucleic Acids Res 2004;32:D493-D496.
19. Kozomara A, Griffiths-Jones S: miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011;39:D152-D157.
20. Vergoulis TI, Vlachos P, Alexiou G, et al.: Tarbase 6.0: capturing the exponentia growth of miRNA targets with experimental support. Nucleic Acids Res 2012;40:D222-D229.
21. Gao J, Ade AS, Tarcea VG, et al.: Integrating and annotating the interactome using the MiMI plugin for cytoscape. Bioinformatics 2009;25:137-138.
22. Bader GD, Hogue CW: An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform 2003;4:2.
23. Maere S, Heymans K, Kuiper M: BiNGO: a cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005;21 3448-3449.
24. Huang DW, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protoc 2009;4:44-57.
25. Thomas PD, Kejariwal A, Campbell MJ, et al.: PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res 2003;31:334-341
26. Mouse Genome Informatics (MGI) Web, The Jackson Laboratory, Bar Harbor, Maine. Available online at www.informatics.jax.org (last accessed on May, 2012)
27. Blake JA, Eppig JT, Richardson JE, et al.: The Mouse Genome Database (MGD): integration nexus for the laboratory mouse. Nucleic Acids Res 2001;29:91-94.
28. Fury W, Batliwalla F, Gregersen PK, et al.: Overlapping probabilities of top ranking gene lists, hypergeometric distribution, and stringency of gene selection criterion. Conf Proc IEEE Eng Med Biol Soc 2006;1:5531-5534.
29. Leppert U, Henke W, Huang X, et al.: Post-transcriptional fine-tuning of COP9 signalosome subunit biosynthesis is regulated by the c-Myc/Lin28B/let-7 pathway. J Mol Biol 2011;409:710-721.
30. Wei N, Serino G, Deng XW: The COP9 signalosome: more than a protease. Trends Biochem Sci 2008;33:592-600.
31. Zhang W, Liu HT: MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 2002;12:9-18.
32. Ramirez C, Antczak C, Djaballah H: Cell viability assessment: toward content-rich platforms. Expert Opin Drug Discov 2010;5:223-233.
33. Krausz E, Korn K: High-content siRNA screening for target identification and validation. Expert Opin Drug Discov 2008;3:551-564.
34. Kummel A, Gubler H, Gehin P, et al.: Integration of multiple readouts into the z' factor for assay quality assessment. J Biomol Screen 2010;15:95-101.
35. Rao DD, Vorhies JS, Senzer N, et al.: siRNA vs. shRNA: similarities and differences. Adv Drug Deliv Rev 2009;61:746-759.
36. Park JE, Heo I, Tian Y, et al.: Dicer recognizes the 5' end of RNA for efficient and accurate processing. Nature 2011;475:201-205.
37. Vermeulen A, Behlen L, Reynolds A, et al.: The contributions of dsRNA structure to dicer specificity and efficiency. RNA 2005;11:674-682.
38. Birmingham A, Anderson EM, Reynolds A, et al.: 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods 2006;3:199-204.
39. Sudbery I, Enright AJ, Fraser AG, et al.: Systematic analysis of off-target effects in an RNAi screen reveals microRNAs affecting sensitivity to TRAIL-induced apoptosis. BMC Genomics 2010;11:175.
40. Wang Z, Pedersen E, Basse A, et al.: Rac1 is crucial for Ras-dependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo. Oncogene 2010;29:3362-3373.
41. Akunuru S, Palumbo J, Zhai QJ, et al.: Rac1 targeting suppressing human non-small cell lung adenocarcinoma cancer stem cell activity. PLoS One 2011;6:e16951.
42. Yan Y, Greer PM, Cao PT, et al.: RAC1 GTPase plays an important role in gamma-irridiation induced G2/M checkpoint activation. Breast Cancer Res 2012;14:R60.
43. Mendoza-Catalán MA, Cristóbal-Mondragón GR, Adame-Gómez J, et al.: Nuclear expression of Rac1 in cervical premalignant lesions and cervical cancer cell lines. BMC Cancer 2012;12:116.
44. Jiang Y, Yim SH, Xu HD, et al.: A potential oncogenic role of the commonly observed E2F5 overexpression in hepatocellular carcinoma. World J Gastroenterol 2011;17:470-477.
45. Polanowska J, Le Cam L, Orsetti B, et al.: Human E2F5 gene is oncogenic in primary rodent cells and is amplified in human breast tumors. Genes Chromosomes Cancer 2000;28:126-130.
46. Teissier S, Pang CL, Thierry F: The E2F5 repressor is an activator of E6/E7 transcription and of the S-phase entry in HPV18-associated cells. Oncogene 2010;29:5061-5070.
47. Ding Y, Huang D, Zhang Z, et al.: Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets. Cancer Res 2011;71:5225-5234.
48. Duan Z, Ji D, Weinstein EJ, Liu X, et al.: Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma. Cancer Lett 2010;293:220-229.
49. Sarthy AV, Morgan-Lappe SE, Zakula D, et al.: Survivin depletion preferentially reduces the survival of activated K0-Ras-transformed cells. Mol Cancer Ther 2007;6:269-276.
50. Zheng M, Morgan-Lappe SE, Yang J, et al.: Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2. Cancer Res 2008;68:7570-7578.
51. Cole KA, Huggins J, Laquaglia M, et al.: RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. Proc Natl Acad Sci USA 2011;108:3336-3341.
52. Luo JL, Emanuele MJ, Li D, et al.: A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 2009;137:835-848.
53. Schlabach MR, Luo J, Solimini NL, et al.: Cancer proliferation gene discovery through functional genomics. Science 2008;319:620-624.
54. Silva JM, Marran K, Parker JS, et al.: Profiling essential genes in human mammary cells by multiplex RNAi screening. Science 2008;319:617-620.
55. Fu J, Bian M, Jiang Q, et al.: Roles of Aurora kinases in mitosis and tumorigenesis. Mol Cancer Res 2007;5:1-10.
56. Harborth J, Elbashir SM, Bechert K, et al.: Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci 2001;114:4557-4565.
57. Yim H, Erikson RL: Polo-like kinase 1 depletion induces DNA damage in early S prior to caspase activation. Mol Cell Biol 2009;29:2609-2621.
58. Chuang CH, Yang D, Bai G, et al.: Post-transcriptional homeostasis and regulation of MCM2-7 in mammalian cells. Nucleic Acids Res 2012;40:4914-4924.
59. Zhu YX, Tiedemann R, Shi C, et al.: RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5. Blood 2011;117:3847-3857.
60. Domínguez-Kelly R, Martín Y, Koundrioukoff S, et al.: Wee1 controls genomic stability during replication by regulating the Mus81-Eme1 endonuclease. J Cell Biol 2011;194:567-579.
61. Luo B, Cheung HW, Subramanian A, et al.: Highly parallel identification of essential genes in cancer cells. Proc Natl Acad Sci USA 2008;105:20380-20385.
62. Dickerson JE, Zhu A, Robertson DL, et al.: Defining the role of essential genes in human disease. PLoS One 2011;6:e27368.